Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline to a range of traditional and eCommerce retailers, wholesalers, and distributors. It includes pharmaceutical products for dentists and other oral health professionals. Its Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Компания Colgate-Palmolive демонстрирует сильные финансовые показатели, включая высокий уровень прибыли и рентабельности. Показатель ROE составляет 325.88, что значительно выше медианы отрасли, что указывает на высокую эффективность использования капитала. Тем не менее, высокие мультипликаторы, такие как P/E 23.94 и P/B 55.50, свидетельствуют о возможной переоцененности акций. Долговая нагрузка также вызывает опасения, так как коэффициент долга к капиталу составляет 5.90, значительно превышая средние значения по отрасли. Дивидендная доходность на уровне 0.61% является положительным фактором, но не компенсирует риски, связанные с высокой задолженностью и переоцененностью акций. В то же время, выручка и чистая прибыль остаются на высоком уровне, что поддерживает позитивный взгляд на компанию. В общем, несмотря на сильные фундаментальные показатели, высокая оценка и долги могут ограничить потенциал роста акций в будущем.

Colgate-Palmolive Company

March has historically been a strong month for the stock market. However, the escalating Middle East conflict involving the United States, Israel, and Iran has shaken markets, prompting investors to seek safer investment options.
Dividend aristocrat stocks like Atmos Energy Corporation ATO, Colgate-Palmolive Company CL and West Pharmaceutical Services, Inc. WST could help provide stability and protect portfolios during periods of market mayhem. Let’s take a closer look at why –
Rising Oil Prices Fuel Inflation Fears, U.S. Stocks Hit
On Thursday, oil prices jumped after Iran unexpectedly struck two oil tankers in Iraqi waters near the key export terminal at Basra. Brent crude has settled above $100 a barrel since Aug. 22, while the West Texas Intermediate crude settled at $95.73 per barrel, according to CNN Business.
The International Energy Agency cautioned that oil supply could remain vulnerable if energy infrastructure across the Middle East region is repeatedly targeted. Regrettably, supply disruptions show little sign of easing after Iran’s current supreme leader, Mojtaba Khamenei, recently said that the Strait of Hormuz should remain shut to apply tactical pressure on adversaries.
The rise in oil prices unnerved investors, as escalating energy costs add to inflationary pressure, threatening economic growth and potentially pushing share prices down. U.S. stock markets continue to face bouts of volatility, particularly affecting airline and travel shares. The Dow, the S&P 500 and the Nasdaq each fell more than 1% on Thursday, with the 30-stock Dow closing below the 47,000 level for the first time this year.
3 Dividend Aristocrats for Stable Income Amid Volatility
As the Middle East crisis rattles markets, with no immediate signs of easing, investors should turn to safer options for consistent income. Dividend aristocrats stand out as they have a long track record of raising dividends, reflecting strong financial stability. Their steady payouts and resilient business models can help cushion portfolios during periods of market volatility like the current crisis.
Here are three dividend aristocrats, with 25+ years of successive dividend increases:
Atmos Energy
Atmos Energy operates regulated natural gas distribution, pipeline and storage businesses in the United States.
Atmos Energy has a dividend yield of 2.17%. ATO’s payout ratio presently sits at 52% of earnings. ATO’s payout has advanced by 8.75% in the past five years. Check Atmos Energy’s dividend history here.
The Zacks Consensus Estimate for its current-year earnings has increased 2.1% over the past 60 days. The company’s expected earnings growth for the current year is 10.2%.
Colgate-Palmolive
Colgate-Palmolive manufactures and sells consumer products in the United States and globally.
Colgate-Palmolive has a dividend yield of 2.32%. CL’s payout ratio presently sits at 56% of earnings. CL’s payout has advanced by 3.36% in the past five years. Check Colgate-Palmolive’s dividend history here.
The Zacks Consensus Estimate for its current-year earnings has increased 1.3% over the past 60 days. The company’s expected earnings growth for the current year is 5.7%.
West Pharmaceutical Services
West Pharmaceutical Services makes containment and delivery systems for injectable drugs and healthcare products worldwide.
West Pharmaceutical Services has a dividend yield of 0.37%. WST’s payout ratio presently sits at 12% of earnings. WST’s payout has advanced by 5.55% in the past five years. Check West Pharmaceutical Services’ dividend history here.
The Zacks Consensus Estimate for its current-year earnings has increased 2.6% over the past 60 days. The company’s expected earnings growth for the current year is 7.8%.
All three of them, Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services, currently have a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks Rank #1 (Strong Buy) stocks here.
Just Released: Zacks Top 10 Stocks for 2026
Hurry – you can still get in early on our 10 top tickers for 2026. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful.
From inception in 2012 through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.
Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2026. You can still be among the first to see these just-released stocks with enormous potential.
See New Top 10 Stocks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

3 Dividend Aristocrats to Buy Now Amid the Middle East Crisis

Applied Materials today announced that its Board of Directors has approved a 15-percent increase in the quarterly cash dividend, from $0.46 to $0.53 per share, payable on June 11, 2026 to shareholders of record as of May 21, 2026. This marks nine consecutive years of dividend increases. "With the increase announced today, Applied Materials has more than doubled its dividend per share from four years ago," said Brice Hill, Senior Vice President and CFO. "This demonstrates our ability to generate strong cash flow and attractive shareholder distributions while investing to enable profitable growth." The cash dividend is a key component of Applied's capital allocation strategy. With the increase announced today, the company has grown its dividend per share at a compound annual growth rate of 18 percent over the past decade. Over the past 10 fiscal years, Applied has distributed nearly 90 percent of free cash flow to shareholders through dividends and share repurchases.
The Board of Directors of Annaly Capital Management declared the first quarter 2026 common stock cash dividend of $0.70 per common share. This dividend is payable April 30, 2026, to common shareholders of record on March 31, 2026. The ex-dividend date is March 31, 2026.
The Kroger's Board of Directors today declared a quarterly dividend of 35 cents per share to be paid on June 1, 2026, to shareholders of record as of the close of business on May 15, 2026. The company's quarterly dividend has grown at a 13% compounded annual growth rate since it was reinstated in 2006.
AGNC Investmeny announced today that its Board of Directors has declared a cash dividend of $0.12 per share of common stock for March 2026. The dividend is payable on April 10, 2026 to common stockholders of record as of March 31, 2026.
The Board of Directors of Colgate-Palmolive today announced an increase in the quarterly common stock cash dividend to $0.53 up from $0.52 per share. The increase will be effective in the second quarter, 2026. The Board declared that the second quarter dividend is to be paid on May 15, 2026, to shareholders of record on April 20, 2026. On an annualized basis, the new dividend rate is $2.12 versus $2.08 per share previously. The Company has paid uninterrupted dividends on its common stock since 1895.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Daily Dividend Report: AMAT,NLY,KR,AGNC,CL

In an environment where global consumer demand remains subdued, innovation has become a central lever for Colgate-Palmolive Company CL to stimulate category growth and strengthen its competitive position. Management emphasized on the latestearnings callthat the company is doubling down on science-based product development and a more structured global innovation model. The goal is to deliver more impactful launches across multiple price tiers while ensuring faster speed to market. By focusing on meaningful product improvements and consumer-centric solutions, Colgate aims not only to defend its leadership in oral care but also to encourage greater usage and premiumization across its daily-use categories.
A key example of this strategy is the continued rollout of the Colgate Total relaunch, which integrates toothpaste, mouthwash and toothbrush products into a broader oral-care regimen. Management noted that momentum from the relaunch is improving as earlier formula adjustments have stabilized and distribution has normalized in several markets. The company is also expanding innovation across different price points to address diverse consumer needs, particularly in emerging markets where affordability remains crucial. These initiatives are designed to drive higher value per consumer while supporting organic growth even in slower category environments.
Innovation also extends beyond oral care into Colgate’s Hill’s Pet Nutrition business, where science-led therapeutic and prescription products continue to generate strong demand. In addition, the company is investing in digital, data and AI capabilities to strengthen its innovation pipeline and improve marketing effectiveness through more personalized, omnichannel engagement. By combining scientific expertise, premium innovation and advanced analytics, Colgate is positioning innovation as a long-term growth engine capable of revitalizing demand and reinforcing its leadership across key categories.
CL’s Zacks Rank & Share Price Performance
Shares of this Zacks Rank #3 (Hold) company have gained 18.1% in the past three months, outperforming both the industry and the broader Consumer Staples sector, which rose 7.3% and 6.3%, respectively.
CL Stock's Three-Month Performance
Image Source: Zacks Investment Research
Is CL a Value Play Stock?
Colgate currently trades at a forward 12-month P/E ratio of 23.43X, which is higher than the industry average of 19.08X and the sector average of 17.358X. This valuation positions the stock at a premium relative to both its sector and industry peers, suggesting that investors may be pricing in stronger growth prospects, brand strength or operational efficiency compared with competitors.
CL P/E Ratio (Forward 12 Months)
Image Source: Zacks Investment Research
Stocks to Consider
Mama's Creations, Inc. MAMA manufactures and markets fresh deli-prepared foods in the United States. At present, it sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for MAMA’s current fiscal-year sales and earnings implies growth of 39.9% and 44.4%, respectively, from the year-ago figures. Mama's Creations delivered a trailing four-quarter earnings surprise of 133.3%, on average.
The Hershey Company HSY engages in the manufacture and sale of confectionery products and pantry items in the United States and internationally. It carries a Zacks Rank #2 (Buy) at present. HSY delivered a trailing four-quarter earnings surprise of 17.2%, on average.
The Zacks Consensus Estimate for Hershey’s current financial-year sales and earnings indicates growth of 4.8% and 29.3%, respectively, from the prior-year reported levels.
US Foods Holding Corp. USFD engages in the marketing, sale and distribution of fresh, frozen and dry food and non-food products to foodservice customers in the United States. It currently carries a Zacks Rank of 2. USFD delivered a trailing four-quarter earnings surprise of 2.2%, on average.
The Zacks Consensus Estimate for US Foods Holding’s current fiscal-year sales and earnings implies growth of 5.4% and 20.9%, respectively, from the year-ago figures.
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Hershey Company (The) (HSY) : Free Stock Analysis Report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Innovation as Growth Engine: How Colgate Plans to Revive Demand

Digital transformation is becoming a key pillar of operational improvement at The Clorox Company CLX. The company is focused on strengthening its foundation by advancing digital transformation, improving execution, and unlocking value from its newly modernized enterprise resource planning (ERP) platform, while accelerating innovation to deliver superior value to consumers in a dynamic environment. As the company modernizes its systems and processes, management believes these initiatives can strengthen efficiency, streamline decision-making and support long-term growth.
A major milestone in this transformation was the completion of the final phase of Clorox’s U.S. ERP implementation. This multi-year initiative was designed to modernize the company’s systems and create a more integrated operating platform. With the transition now complete, Clorox is focused on leveraging the new infrastructure to improve execution across supply chain, demand planning and operational processes.
Management emphasized that its new operating model, supported by significant digital investments, is enabling the company to scale capabilities and enhance operational efficiency. The platform is expected to accelerate decision-making while enabling more data-driven insights across the organization. These capabilities are also strengthening revenue growth management and allowing Clorox to execute more personalized and insight-driven strategies in the marketplace. The company continues to invest meaningfully in these capabilities. Strategic spending aimed at enhancing digital infrastructure and productivity initiatives remains an important component of Clorox’s cost structure, reflecting management’s confidence in the long-term benefits of the transformation.
These digital capabilities also support Clorox’s broader strategy of driving innovation and improving the consumer shopping experience. By integrating data, analytics and supply chain visibility, the company aims to create more efficient operations while strengthening brand execution. While the ERP transition has created some near-term operational challenges, Clorox believes the upgraded digital foundation positions it for stronger efficiency and execution over time. If successfully leveraged, these investments could enhance productivity, improve margin resilience and support sustainable long-term growth.
The Zacks Rundown for CLX
In the past three months, CLX’s shares have gained 10.2% compared with the industry’s rise of 8%. CLX carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 17.33X, lower than the industry average of 19.03X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CLX’s current fiscal year earnings implies a year-over-year decline of 23.5%, while the same for the next fiscal year earnings suggests a year-over-year rise of 15.3%.
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks have been discussed below:
Colgate-Palmolive Company CL together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. CL currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for CL's current fiscal-year sales and earnings implies growth of 4% and 5.7%, from the year-ago reported figures. CL delivered a trailing four-quarter earnings surprise of 4%, on average.
Ollie's Bargain Outlet Holdings, Inc. OLLI operates as a retailer of closeout merchandise and excess inventory in the United States. OLLI currently carries a Zacks Rank #2.
The Zacks Consensus Estimate for OLLI's current fiscal-year sales and earnings implies growth of 16.8% and 17.7%, respectively, from the year-ago actuals. OLLI delivered a trailing four-quarter earnings surprise of 5.2%, on average.
Kenvue Inc. KVUE operates as a consumer health company in the United States, the rest of North America, Europe, the Middle East, Africa, the Asia-Pacific and Latin America. KVUE currently carries a Zacks Rank #2.
The Zacks Consensus Estimate for KVUE's current fiscal-year sales and earnings implies growth of 2.9% and 0.9%, respectively, from the year-ago actuals. KVUE delivered a trailing four-quarter negative earnings surprise of 9.8%, on average.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.
See
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Can Clorox's Digital Push Accelerate Operational Efficiency?

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Consumer Staples Select Sector SPDR Fund (Symbol: XLP) where we have detected an approximate $558.8 million dollar inflow -- that's a 3.4% increase week over week in outstanding units (from 192,821,809 to 199,321,809). Among the largest underlying components of XLP, in trading today Procter & Gamble Company (Symbol: PG) is off about 0.4%, Colgate-Palmolive Co. (Symbol: CL) is down about 1.2%, and Altria Group Inc (Symbol: MO) is lower by about 0.2%. For a complete list of holdings, visit the XLP Holdings page » The chart below shows the one year price performance of XLP, versus its 200 day moving average:
Looking at the chart above, XLP's low point in its 52 week range is $75.16 per share, with $90.14 as the 52 week high point — that compares with a last trade of $85.88. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ».
Free Report: Top 8%+ Dividends (paid monthly)
Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs.
Also see:
TPVG market cap history
CM Options Chain
Institutional Holders of KREP
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Noteworthy ETF Inflows: XLP, PG, CL, MO

The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Colgate-Palmolive is now the #152 analyst pick, moving up by 1 spot.
This rank is formed by averaging the analyst opinions for each component from each broker, and then ranking the 500 components by those average opinion values.
Looking at the stock price movement year to date, Colgate-Palmolive is showing a gain of 18.1%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

S&P 500 Analyst Moves: CL

Last Friday, all three Wall Street benchmark stock indexes registered weekly losses. The Dow Jones Industrial Average fell 2.89%, the S&P 500 declined 1.75% and the Nasdaq Composite slipped 0.59%.
The downturn was largely due to a sharp surge in crude oil prices and escalating geopolitical tensions in the Middle East, which heightened concerns about inflation and global economic growth. Rising energy costs weighed on several sectors, particularly materials, industrials and consumer staples, while investors also remained cautious ahead of key U.S. economic data that could influence the Fed’s interest-rate outlook. The combination of geopolitical uncertainty and inflation worries triggered broad market volatility and risk-off sentiment among investors.
Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market.
As usual, Zacks Research guided investors over the past three months with its time-tested methodologies. Given the prevailing market uncertainty, you may want to look at our feats to prepare better for your next action.
Here are some of our key achievements:
Allogene Therapeutics and Moog Surge Following Zacks Rank Upgrade
Shares of Allogene Therapeutics, Inc. ALLO have gained 70.4% (versus the S&P 500’s 1.6% decrease) since it was upgraded to a Zacks Rank #2 (Buy) on January 5.
Another stock, Moog Inc. MOG.A, which was also upgraded to a Zacks Rank #2 on January 5, has returned 26.8% since then.
An equal-weight portfolio of Zacks Rank # 1 (Strong Buy) stocks outperformed the equal-weight S&P 500 index by 7 percentage points (+17.81% for the Zacks Rank #1 stocks vs. +10.85% for the index).
This hypothetical equal-weight portfolio returned +22.4% in 2024 vs. +13.7% for the equal-weight S&P 500 index. Over the preceding 10-year period (2016 through 2025), this portfolio of qual-weight Zacks Rank #1 stocks has outperformed the equal-weight S&P 500 index by more than 7 percentage points (+18.55% vs. +11.65%).
Image Source: Zacks Investment Research
Zacks Recommendation Upgrades Yankuang Energy and FormFactor
Shares of Yankuang Energy Group Company Limited YZCAY and FormFactor, Inc. FORM have surged 31.7% and 16.3% (versus the S&P 500’s 3.3% fall), respectively, since their Zacks Recommendation was upgraded to Outperform on January 13.
While the Zacks Rank is our short-term rating system that is most effective over the one- to three-month holding horizon, the Zacks Recommendation aims to predict performance over the next 6 to 12 months. However, just like the Zacks Rank, the foundation for the Zacks Recommendation is trends in earnings estimate revisions.
The Zacks Recommendation classifies stocks into three groups — Outperform, Neutral and Underperform. While these recommendations are determined quantitatively, our analysts have the flexibility to override them for the 1100+ stocks they closely follow based on their better judgment of factors such as valuation, industry conditions and management effectiveness than the quantitative model.
To access our research reports with Zacks Recommendations for the 1100+ stocks we cover, click here>>>
Zacks Focus List Stocks Micron, Intellia Shoot Up
Shares of Micron Technology, Inc. MU, which belongs to the Zacks Focus List, have gained 46.7% over the past 12 weeks. The stock was added to the Focus List on December 27, 2016. Another Focus-List holding, Intellia Therapeutics, Inc. NTLA, which was added to the portfolio on March 7, 2023, has returned 44.5% over the past 12 weeks. The S&P 500 has declined 1.6% over this period.
The 50-stock Focus List portfolio returned +5.22% in January 2026 vs. +1.45% for the S&P 500 index and +3.39% for the equal-weight version of the index.
The portfolio returned +22.1% in 2025 vs. +17.9% for the S&P 500 index and +11.4% for the equal-weight version of the index.
The Zacks Focus List portfolio returned +18.41% in 2024 vs. +25.04% for the S&P 500 index and +13% for the equal-weight S&P 500 index. The portfolio had returned +29.54% in 2023 vs. +26.28% for the S&P 500 index and +13.61% for the equal-weight S&P 500 index. In 2022, the portfolio returned -15.2% vs. the S&P 500 index’s -17.96%.
Through January 31st, 2026, the portfolio’s rolling one-year, three-years, five-years, ten-years and since 2004 has been +22.2% (vs. +16.35% for the S&P 500 index), +21.55% (vs. +21.12%), +15.13% (vs. +14.99%), +16.59% (vs. +15.57%) and +12.36% vs. (+10.74%), respectively.
Unlock all of our powerful research, tools and analysis, including the Focus List, Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. Gain full access now >>
Zacks ECAP Stocks Hershey’s & Colgate-Palmolive Gain Significantly
The Hershey Company HSY, a component of our Earnings Certain Admiral Portfolio (ECAP), has jumped 25.9% over the past 12 weeks. Colgate-Palmolive Company CL followed Hershey with 21.5% returns.
The Zacks Earnings Certain Admiral Portfolio (ECAP), which consists of 30 concentrated, ultra-defensive, long-term Buy-and-Hold stocks, returned -2.3% in the fourth quarter of 2025 vs. the S&P 500 index’s +2.7% gain (SPY ETF). For 2025 as a whole, the portfolio returned -1.67% vs. +17.9% gain for the S&P 500 index.
For the year 2024, the portfolio returned +16.26% vs. +24.89% for the S&P 500 index (SPY ETF).
In 2023, the portfolio returned +12.17% vs. +26.28% for the S&P 500 index. The portfolio returned -4.7% in 2022 vs. the S&P 500 index’s -17.96%.
With little to no turnover and annual rebalance periodicity, ECAP seeks to minimize capital loss by holding shares of companies whose earnings streams exhibit a proven 20+ year track record of surviving recessionary periods with minimal impact on aggregate earnings growth relative to the overall S&P 500.
The ECAP and many other model portfolios are available as part of Zacks Advisor Tools, a cloud-based solution to access Zacks award-winning stock, mutual fund and ETF research. Click here to schedule a demo.
Zacks ECDP Stocks Starbucks and Amgen Outperform Peers
Starbucks Corporation SBUX, which is part of our Earnings Certain Dividend Portfolio (ECDP), has returned 20.3% over the past 12 weeks. Another ECDP stock, Amgen Inc. AMGN, has climbed 17.7% over the same time frame. Of course, the inclination of investors toward quality dividend stocks to secure an income stream amid heightened market volatility contributed to this performance.
With an extremely low beta and a history of minimum earnings variability over the last 20+ years, this 25-stock portfolio helps significantly mitigate risk.
The Zacks Earnings Certain Dividend Portfolio (ECDP) returned -2.1% in 2025 Q4 vs. the S&P 500 index’s +2.7% gain and the Dividend Aristocrats ETF’s (NOBL) +1.6% return. For 2025, the portfolio returned -0.6% vs. +6.8% gain for the Dividend Aristocrat ETF.
For the full year 2024, the portfolio returned +6.95% vs. +24.89% for the S&P 500 index and +6.72% for NOBL.
The portfolio returned -0.9% in 2023 vs. +26.28% for the S&P 500 index and +8.11% for NOBL. The portfolio returned -2.3% in 2022 vs. -17.96% for the S&P 500 index and -8.34% for NOBL.
Click here to access this portfolio on Zacks Advisor Tools.
Zacks Top 10 Stock VSE Corporation Delivers Solid Returns
VSE Corporation VSEC, from the Zacks Top 10 Stocks for 2025, has jumped 15.5% since January 5, 2026, compared with the S&P 500 Index’s 1.6% decrease.
The Top 10 portfolio retuned +4.88% in January 2026 vs. +1.45% for the S&P 500 index and +3.39% for the equal-weight version of the index.
The Top 10 portfolio returned +22.6% in 2025 vs. +17.9% for the S&P 500 index and +11.4% for the equal-weight version of the index.
The Top 10 portfolio returned +62.98% in 2024, vs. +25.04% for the S&P 500 index and +13% for the equal-weight version of the index. The portfolio had returned +25.15% in 2023 vs. +26.28% for the S&P 500 index.
Through the end of January 2026, the Top 10 portfolio has produced a cumulative return of +2,616.9% since 2012 vs. +578.2% for the S&P 500 index and +416.7% for the equal-weight version of the index. The portfolio has produced an average annual return of +26.4% in the period 2012 through January 31st, 2026 vs. +14.8% for the S&P 500 index and +12.4% for the equal-weight version of the index.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus

Companies in the Consumer Products-Staples are leveraging strategic optimization initiatives to strengthen revenue streams and enhance long-term positioning. Expanding e-commerce ecosystems, innovation in health-focused and sustainable offerings, and disciplined portfolio reshaping through acquisitions and divestitures are enabling companies to concentrate resources on higher-growth, higher-return categories.
At the same time, resilient demand for essential products continues to support industry stability. Despite shifting spending patterns, staples remain largely non-discretionary, reinforcing consistent consumption trends. Companies such as Procter & Gamble Company PG, Colgate-Palmolive Company CL, BJ's Wholesale Club Holdings, Inc. BJ and Ollie's Bargain Outlet Holdings, Inc. OLLI are leveraging these structural tailwinds to strengthen competitive positioning and drive sustainable growth.
About the Industry
The Zacks Consumer Products-Staples industry includes companies that manufacture, market and distribute a broad range of everyday household and personal-use items. These offerings span personal care products, cleaning tools, stationery, bed and bath essentials and general household goods such as small appliances, cutlery and food-storage solutions. Some players also participate in categories like batteries, lighting, pet food, treats and related supplies. Their products reach consumers through supermarkets, drug and grocery chains, department stores, mass merchandisers, warehouse clubs and other retail partners, while a growing share is now sold through digital channels. Several companies also supply items to perfume, cosmetics and personal-care manufacturers, as well as to third-party distributors.
Trends Shaping the Future of the Consumer Products-Staples Industry
Maximizing Revenues Through Strategic Optimization: Companies are actively pursuing strategic levers to strengthen their revenue base and long-term positioning. E-commerce and digital capabilities continue to expand, supporting both convenience-driven demand and higher-margin direct-to-consumer models. Innovation efforts are aligned with evolving consumer expectations for healthier formulations, environmentally responsible packaging and frictionless, tech-enabled engagement. Simultaneously, many firms are reshaping their portfolios through targeted acquisitions and divestitures, enabling a more focused allocation of capital to faster-growing, higher-return categories. Together, these initiatives are helping industry players sustain relevance and drive incremental growth in a rapidly transforming market landscape.
Resilient Demand for Essential Products: The consumer staples industry continues to benefit from steady demand, supported by its exposure to everyday-use categories. This structural stability tends to persist across economic cycles, as household and personal care products remain non-discretionary in nature. While consumer spending patterns may shift in response to macroeconomic pressures, demand for essential goods generally remains intact. Elevated cost-of-living concerns have encouraged value-seeking behavior and at-home consumption trends, reinforcing consistent demand across core staple categories.
Rising Cost Pressures in a Difficult Operating Environment: The consumer goods industry is under pressure from rising costs in raw materials, labor and transportation. These elevated input costs weigh on profit margins, especially when companies are unable to fully offset them through price increases. Compounding the challenge are higher SG&A expenses, along with increased investments in digital transformation and marketing to drive growth. Many firms are vulnerable to shipping disruptions, which can result in delays and higher freight expenses, squeezing overall profit margins. To safeguard margins, many companies are implementing restructuring initiatives and cost-cutting strategies aimed at improving operational efficiency and sustaining profitability in this demanding environment.
Zacks Industry Rank Indicates Bright Prospects
The Zacks Consumer Products-Staples industry is housed within the broader Zacks Consumer Staples sector. The industry currently carries a Zacks Industry Rank #74, which places it in the top 31% of more than 243 Zacks industries.
The group’s Zacks Industry Rank, which is the average of the Zacks Rank of all member stocks, indicates dim near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one.
The industry’s position in the top 50% of the Zacks-ranked industries is a result of a positive aggregate earnings outlook for its constituent companies. Since the beginning of December 2025, the industry’s consensus earnings estimate for the current financial year has improved 0.6%.
Let’s look at the industry’s performance and current valuation.
Industry vs. Broader Market
The Zacks Consumer Products-Staples industry has lagged the S&P 500 index and the broader Zacks Consumer Staples sector over the past six months.
The industry has gained 1.1% over this period compared with the broader sector’s growth of 7.7%. Meanwhile, the S&P 500 index has advanced 8%.
Six-Month Price Performance
Industry's Current Valuation
On the basis of forward 12-month price-to-earnings (P/E), commonly used for valuing consumer staple stocks, the industry is currently trading at 20.06X compared with the S&P 500’s 22.41X and the sector’s 18.25X.
Over the past five years, the industry has traded as high as 23.39X, as low as 18.20X and at the median of 21.27X, as the chart below shows.
Price-to-Earnings Ratio (Past Five Years)
4 Consumer Product Stocks to Keep a Close Eye On
Ollie’s Bargain: Ollie’s continues to strengthen its competitive standing through a disciplined, value-focused operating model backed by effective merchandising and prudent expense management. This Zacks Rank #2 (Buy) benefits from its loyalty platform, Ollie’s Army, which serves as a key strategic lever by enhancing customer engagement and encouraging repeat visits, reinforcing its position in the closeout retail landscape. Consistent access to compelling brand-name deals, combined with ongoing investments in supply-chain capabilities and geographic expansion, supports operational productivity and long-term scalability. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Ollie’s current fiscal year earnings per share (EPS) has remained unchanged at $3.86 in the past seven days. This indicates growth of 17.7% year over year. OLLI has seen its shares declined 19.4% in the past six months.
Price and Consensus: OLLI
BJ's Wholesale Club: A leading operator of membership warehouse clubs, BJ currently carries a Zacks Rank #2. The company continues to exhibit steady momentum, supported by its strategic emphasis on membership expansion and digital transformation initiatives. BJ remains focused on strengthening its omnichannel ecosystem while reinforcing the core value proposition. These efforts have supported consistent growth in member acquisition and retention, contributing to stable membership fee income. By offering convenient solutions such as same-day delivery, curbside pickup and buy online, pick up in club, the company delivers a seamless and engaging shopping experience. In addition, BJ’s Wholesale Club has been methodically expanding its physical footprint, targeting attractive growth markets and underserved regions to drive long-term scalability.
The Zacks Consensus Estimate for BJ's Wholesale Club’s current fiscal-year EPS has been increased from $4.36 to $4.37 in the past seven days. The projection indicates growth of 7.9% from the year-ago period’s level. BJ’s shares have gained 4.2% in the past six months.
Price and Consensus: BJ
Procter & Gamble: This Zacks Rank #3 (Hold) company continues to demonstrate durable market leadership through a world-class brand portfolio, strong innovation pipelines and superior in-market execution. The company is benefiting from productivity initiatives, disciplined pricing and steady volume trends, alongside healthy consumer engagement across its core categories. Its focus on digital capabilities, retailer partnerships and a balanced premium brand mix further reinforces competitive strength and operating leverage. With a disciplined strategy and broad global reach, P&G remains positioned to deliver steady, long-term value creation.
The Zacks Consensus Estimate for Procter & Gamble’s current fiscal-year EPS has remained unchanged at $6.97 in the past seven days. This indicates growth of 2.1% from the year-ago period. PG’s shares have risen 0.9% in the past six months.
Price and Consensus: PG
Colgate: This Zacks Rank #3 company is a global leader in the oral care market. The company continues to benefit from effective pricing strategies and ongoing productivity and reinvestment initiatives. It is actively investing in both core and premium product innovations, while increasing advertising support to enhance brand visibility and household penetration. Moreover, Colgate is expanding its digital, data and analytics capabilities, strengthening the competitive edge and supporting long-term profitability in a dynamic consumer environment.
The Zacks Consensus Estimate for Colgate’s current fiscal-year EPS has remained unchanged at $3.90 in the past seven days, indicating growth of 5.7% from the year-ago period’s level. Shares of the company have gained 14% in the past six months.
Price and Consensus: CL
Free Report: Profiting from the 2nd Wave of AI Explosion
The next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.
Investors who bought shares like Nvidia at the right time have had a shot at huge gains.
But the rocket ride in the "first wave" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.
Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.
Access AI Boom 2.0 now, absolutely free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

4 Consumer Product Stocks Set to Benefit From Strong Industry Momentum

As Grocery Outlet Holdings Corporation GO prepares to unveil its fourth-quarter fiscal 2025 earnings on March 4, after market close. Investors are eager to see if the company can beat market expectations.
The Zacks Consensus Estimate for revenues is pegged at $1.24 billion, implying 12.5% growth from the prior year. Meanwhile, the consensus mark for earnings has been steady at 21 cents per share over the past 30 days, and calls for growth of 40% from the year-ago period. GO has a trailing four-quarter earnings surprise of 29.9%, on average.
Grocery Outlet Holding Corp. Price, Consensus and EPS Surprise
Key Factors to Observe for GO's Q4 Earnings
Grocery Outlet’s fourth-quarter performance is likely to have benefited from the continued strength of its differentiated off-price model, which centers on opportunistic sourcing of quality, name-brand consumables and fresh products. The company is executing on multiple growth levers, including deeper market penetration, expanding private-label offerings, and renewed merchandising discipline, all of which support traffic and strengthen its value proposition in a cautious consumer environment.
Another key driver heading into the final quarter has been the rollout of the store refresh initiative, which Grocery Outlet began piloting in the third quarter and plans to expand broadly. The refresh program focuses on improving store layout, standardizing and expanding core assortments and elevating in-store value messaging. As additional stores were refreshed late in the year, improved ease of shop, better in-stock positions and clearer communication of value are likely to have enhanced the customer experience and contributed positively to sales trends.
That said, certain headwinds may have tempered fourth-quarter performance. In the third quarter, gross margin faced pressure from promotional activity and markdowns tied to seasonal inventory, and while management course-corrected its marketing and promotional mix, the lingering effects of softer traffic are likely to have extended into the early fourth quarter. We expect comparable-store sales to rise 0.4% in the final quarter, showing a sharp deceleration from preceding quarters.
What the Zacks Model Says About GO’s Q4 Earnings
As investors prepare for Grocery Outlet’s fourth-quarter announcement, the question looms regarding earnings beat or miss. Our proven model does not conclusively predict an earnings beat for GO this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, that’s not the case here.
GO has an Earnings ESP of -0.04% and a Zacks Rank #4 (Sell). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks With the Favorable Combination
Here are three companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season:
BJ’s Wholesale Club Holdings, Inc. BJ has an Earnings ESP of +5.69% and currently carries a Zacks Rank of 2. The Zacks Consensus Estimate for fourth-quarter fiscal 2025 earnings per share is pegged at 93 cents, remaining flat compared to the previous year. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for quarterly revenues is pegged at $5.6 billion, which indicates an increase of 6.2% from the figure reported in the prior-year quarter. BJ has a trailing four-quarter earnings surprise of 10.3%, on average.
Colgate-Palmolive Company CL has an Earnings ESP of +0.26% and currently carries a Zacks Rank of 3. The Zacks Consensus Estimate for first-quarter fiscal 2025 earnings per share is pegged at 95 cents, implying 4.4% year-over-year growth.
The Zacks Consensus Estimate for quarterly revenues is pegged at $5.2 billion, which indicates an increase of 5.6% from the figure reported in the prior-year quarter. CL has a trailing four-quarter earnings surprise of 4%, on average.
Kimberly-Clark Corporation KMB has an Earnings ESP of +0.84% and currently carries a Zacks Rank of 3. The Zacks Consensus Estimate for first-quarter fiscal 2026 earnings per share is pegged at $1.79, implying a 7.3% year-over-year decline.
The Zacks Consensus Estimate for quarterly revenues is pegged at $4.1 billion, which indicates a decline of 14.9% from the figure reported in the prior-year quarter. KMB has a trailing four-quarter earnings surprise of 18.9%, on average.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They include
Stock #1: A Disruptive Force with Notable Growth and Resilience
Stock #2: Bullish Signs Signaling to Buy the Dip
Stock #3: One of the Most Compelling Investments in the Market
Stock #4: Leader In a Red-Hot Industry Poised for Growth
Stock #5: Modern Omni-Channel Platform Coiled to Spring
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.
See Our Newest 5 Stocks Set to Double Picks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

GO's Q4 Earnings Coming Up: Will the Stock Extend Its Beat Streak?

Brown-Forman Corporation BF.B is slated to release third-quarter fiscal 2026 results on March 4. The alcoholic beverage bigwig’s revenues and earnings are expected to have declined year over year in the quarter under review. The Zacks Consensus Estimate for fiscal third-quarter revenues is pegged at $999.7 million, indicating a decline of 3.4% from the year-ago quarter’s actual.
The consensus mark for earnings is pegged at 48 cents per share, indicating a decrease of 15.8% from the year-ago period’s reported number. Earnings estimates for the fiscal third quarter have been unchanged in the past 30 days.
In the last reported quarter, the company’s earnings missed the Zacks Consensus Estimate by 2.1%. In the trailing four quarters, BF.B delivered an earnings surprise of 0.7%, on average.
Brown-Forman Corporation Price and EPS Surprise
Key Factors Likely to Affect BF.B’s Q3 Results
Brown-Forman has been grappling with a volatile and competitive operating landscape, owing to geopolitical uncertainties and global macroeconomic conditions. A tepid macroeconomic landscape, including softened consumer demand and dampened discretionary spending across key markets, has been weighing on Brown-Forman’s quarterly performance. The company has been witnessing lower volumes across brands and regions. Soft industry trends, led by the absence of the Finlandia and Sonoma-Cutrer brands, and the adverse impacts of currency, have been concerning.
Lower volumes of Jack Daniel’s Tennessee Whiskey, Herradura and Jack Daniel’s Tennessee Honey, and the conclusion of the Korbel relationship and the absence of the Sonoma-Cutrer prior-year TSA, have been acting as deterrents. Brown-Forman’s performance reflects cost pressures and evolving portfolio dynamics.
Higher costs due mainly to inflation on input costs, and a reduction in production levels and an unfavorable price mix have been headwinds. Brown-Forman has been contending with consumer caution, the looming threat of tariffs and other related concerns. On its last reported quarter’searnings call management had expected organic operating expenses to continue reflecting investments in brands. The impacts of these trends are expected to be evident in the company’s results in the to-be-reported quarter.
On the flip side, Brown-Forman’s premiumization strategy, pricing efforts, global expansion and revenue-growth management initiatives appear encouraging. The company has been gaining traction from portfolio evolution and a global diversification strategy. Jack Daniel's and Coca-Cola RTD have been strong additions to the portfolio, reflecting progress on its commitment to the premiumization of its portfolio.
Strength in emerging markets has been a bright spot. The company integrated the two super-premium brands — Gin Mare and Diplomatico — in the Rest of the Portfolio category. These are likely to have aided BF.B’s performance in the to-be-reported quarter.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Brown-Forman this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Brown-Forman has an Earnings ESP of 0.00% and a Zacks Rank of 3 at present.
BF.B’s Valuation Picture & Price Performance
From a valuation perspective, Brown-Forman’s shares trade at a premium relative to the industry benchmarks. It has a forward 12-month price-to-earnings ratio of 16.56X, which is slightly lower than the Beverages - Alcohol industry’s average of 16.58X. The stock has a five-year high of 42.22X.
Image Source: Zacks Investment Research
The recent market movements show that BF.B shares have lost 4.1% in the past three months against the industry's 17.2% growth.
Image Source: Zacks Investment Research
Stocks With the Favorable Combination
Here are some companies, which, according to our model, have the right combination of elements to post an earnings beat:
Conagra Brands CAG currently has an Earnings ESP of +1.49% and a Zacks Rank of 3. The company is likely to register declines in its top and bottom lines when it reports third-quarter fiscal 2026 numbers. The Zacks Consensus Estimate for CAG’s quarterly revenues is pegged at $2.8 billion, which indicates a 2.6% rise from the prior-year quarter’s actual. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for Conagra Brands’ quarterly earnings per share is pegged at 40 cents, indicating a 21.6% increase from that reported in the year-ago period. CAG has a trailing four-quarter earnings surprise of 3.4%, on average.
Colgate-Palmolive Company CL currently has an Earnings ESP of +0.26% and a Zacks Rank of 3. The company is likely to register growth in its top and bottom lines when it reports first-quarter 2026 numbers. The Zacks Consensus Estimate for Colgate’s quarterly revenues is pegged at $5.2 billion, which indicates growth of 5.6% from the prior-year quarter’s reported number.
The consensus estimate for Colgate’s quarterly earnings per share is pegged at 95 cents, suggesting 4.4% year-over-year growth. CL has a trailing four-quarter earnings surprise of 4%, on average.
Celsius CELH currently has an Earnings ESP of +2.91% and a Zacks Rank of 3. The company is likely to register increases in the top and bottom lines when it reports first-quarter 2026 numbers. The Zacks Consensus Estimate for quarterly earnings per share is pegged at 27 cents, indicating a 50% jump from the year-ago period’s reported number.
The consensus estimate for Celsius’ quarterly revenues is pegged at $718.3 million, which implies an upsurge of 118.2% from the prior-year quarter’s actual. CELH has a trailing four-quarter earnings surprise of 45.3%, on average.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They include
Stock #1: A Disruptive Force with Notable Growth and Resilience
Stock #2: Bullish Signs Signaling to Buy the Dip
Stock #3: One of the Most Compelling Investments in the Market
Stock #4: Leader In a Red-Hot Industry Poised for Growth
Stock #5: Modern Omni-Channel Platform Coiled to Spring
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.
See Our Newest 5 Stocks Set to Double Picks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.